Workflow
南京健友生化制药股份有限公司2024年年度权益分派实施公告

Core Points - The company announced a cash dividend distribution of 0.1 yuan per share for the fiscal year 2024, totaling approximately 161.56 million yuan [2][4] - The dividend distribution plan was approved at the company's annual general meeting on May 20, 2025 [2][6] - The cash dividends will be distributed to all shareholders registered with the China Securities Depository and Clearing Corporation Limited, Shanghai Branch, as of the close of trading on the record date [3] Dividend Distribution Details - The total share capital before the distribution is 1,615,634,969 shares, with a cash dividend of 0.1 yuan per share [4] - Shareholders who have completed designated trading can receive their cash dividends on the distribution date at their designated securities firms [5] - For shareholders holding unrestricted circulating shares, the cash dividend will be distributed through the clearing system of the China Securities Depository and Clearing Corporation [5] Taxation Information - For individual shareholders holding unrestricted circulating shares for more than one year, the cash dividend is exempt from personal income tax, resulting in an actual distribution of 0.1 yuan per share [8] - For shares held for one year or less, the company will not withhold personal income tax at the time of distribution, but tax will be calculated based on the holding period when the shares are sold [8] - For qualified foreign institutional investors (QFII), a 10% withholding tax will apply, resulting in a net cash dividend of 0.09 yuan per share [10] Convertible Bond Adjustment - The company announced an adjustment to the conversion price of its convertible bonds, "Jianyou Convertible Bonds," effective June 5, 2025, changing from 24.44 yuan to 24.34 yuan per share [14][16] - The adjustment is based on the company's 2024 annual profit distribution plan, which includes a cash dividend distribution [15][16] - The conversion of the bonds will be suspended from May 28 to June 4, 2025, and will resume on June 5, 2025 [16]